Trade Puma Biotechnology, Inc. - PBYI CFD
Add to favourite- Summary
- Historical Data
Spread | 0.0220 | ||||||||
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023512% | ||||||||
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.00129% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5.00% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
Prev. Close | 2.904 |
Open | 2.994 |
1-Year Change | -55.71% |
Day's Range | 2.874 - 3.034 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Feb 21, 2025 | 2.8940 | -0.0100 | -0.34% | 2.9040 | 3.0540 | 2.8640 |
Feb 20, 2025 | 2.9040 | 0.1000 | 3.57% | 2.8040 | 2.9240 | 2.8040 |
Feb 19, 2025 | 2.8740 | 0.0600 | 2.13% | 2.8140 | 2.9140 | 2.7940 |
Feb 18, 2025 | 2.8640 | 0.0900 | 3.24% | 2.7740 | 2.9140 | 2.7740 |
Feb 14, 2025 | 2.8340 | -0.0100 | -0.35% | 2.8440 | 2.9640 | 2.8340 |
Feb 13, 2025 | 2.8940 | 0.1500 | 5.47% | 2.7440 | 2.9240 | 2.7340 |
Feb 12, 2025 | 2.7840 | 0.1000 | 3.73% | 2.6840 | 2.8040 | 2.6840 |
Feb 11, 2025 | 2.7440 | -0.0100 | -0.36% | 2.7540 | 2.7940 | 2.6740 |
Feb 10, 2025 | 2.7740 | 0.0000 | 0.00% | 2.7740 | 2.8440 | 2.7440 |
Feb 7, 2025 | 2.7740 | -0.0300 | -1.07% | 2.8040 | 2.8640 | 2.7640 |
Feb 6, 2025 | 2.8740 | 0.0200 | 0.70% | 2.8540 | 2.9340 | 2.8540 |
Feb 5, 2025 | 2.8940 | 0.1000 | 3.58% | 2.7940 | 2.9440 | 2.7940 |
Feb 4, 2025 | 2.8040 | 0.1700 | 6.45% | 2.6340 | 2.8640 | 2.6340 |
Feb 3, 2025 | 2.7640 | 0.0100 | 0.36% | 2.7540 | 2.8740 | 2.7040 |
Jan 31, 2025 | 2.8740 | -0.1300 | -4.33% | 3.0040 | 3.0540 | 2.8540 |
Jan 30, 2025 | 3.0140 | -0.0500 | -1.63% | 3.0640 | 3.0940 | 2.9240 |
Jan 29, 2025 | 3.0640 | 0.1600 | 5.51% | 2.9040 | 3.1540 | 2.9040 |
Jan 28, 2025 | 3.0240 | 0.1300 | 4.49% | 2.8940 | 3.0440 | 2.8940 |
Jan 27, 2025 | 2.9540 | 0.0700 | 2.43% | 2.8840 | 3.0740 | 2.8840 |
Jan 24, 2025 | 2.9440 | -0.0100 | -0.34% | 2.9540 | 3.0340 | 2.9240 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Puma Biotechnology Company profile
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States. Its drug candidates include PB272 neratinib (oral) for the treatment of early stage breast cancer, metastatic breast cancer, non-small cell lung cancer, HER2 mutation-positive solid tumors, and HER2-mutated non-amplified breast cancer; and PB272 neratinib (intravenous). The company also develops PB357, an orally administered agent that is an irreversible tyrosine kinase inhibitor that blocks signal transduction through the epidermal growth factor receptors, HER1, HER2, and HER4. It has a license agreement with Pfizer, Inc. for the development, manufacture, and commercialization of PB272 neratinib (oral), PB272 neratinib (intravenous), PB357, and certain related compounds. Puma Biotechnology, Inc. was founded in 2010 and is headquartered in Los Angeles, California.Industry: | Biotechnology & Medical Research (NEC) |
10880 Wilshire Blvd.
Suite 2150
LOS ANGELES
CALIFORNIA 90024
US
News

Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025
Ripple XRP price prediction: Third-party price target
Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com
15:29, 6 February 2025
Apple (AAPL) stock price forecast: third-party price target
We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.
11:22, 6 February 2025
FARTCOIN price prediction: Third-party price target
Read our FARTCOIN price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:18, 29 January 2025
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com